Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Noncompetitive, Voltage-Dependent NMDA Receptor Antagonism by Hydrophobic Anions

Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
Molecular Pharmacology February 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794
Andrew J. Linsenbardt
Department of Psychiatry (A.J.L, A.Y.,H-J. S., C.F.Z., S.M.), Taylor Family Institute for Innovative Psychiatric Research (C.F.Z., S.M.), Department of Anatomy & Neurobiology (C.F.Z., S.M.), Washington University School of Medicine, St. Louis, Missouri; and Department of Clinical and Molecular Biomedicine (M.C.), Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariangela Chisari
Department of Psychiatry (A.J.L, A.Y.,H-J. S., C.F.Z., S.M.), Taylor Family Institute for Innovative Psychiatric Research (C.F.Z., S.M.), Department of Anatomy & Neurobiology (C.F.Z., S.M.), Washington University School of Medicine, St. Louis, Missouri; and Department of Clinical and Molecular Biomedicine (M.C.), Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Yu
Department of Psychiatry (A.J.L, A.Y.,H-J. S., C.F.Z., S.M.), Taylor Family Institute for Innovative Psychiatric Research (C.F.Z., S.M.), Department of Anatomy & Neurobiology (C.F.Z., S.M.), Washington University School of Medicine, St. Louis, Missouri; and Department of Clinical and Molecular Biomedicine (M.C.), Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong-Jin Shu
Department of Psychiatry (A.J.L, A.Y.,H-J. S., C.F.Z., S.M.), Taylor Family Institute for Innovative Psychiatric Research (C.F.Z., S.M.), Department of Anatomy & Neurobiology (C.F.Z., S.M.), Washington University School of Medicine, St. Louis, Missouri; and Department of Clinical and Molecular Biomedicine (M.C.), Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles F. Zorumski
Department of Psychiatry (A.J.L, A.Y.,H-J. S., C.F.Z., S.M.), Taylor Family Institute for Innovative Psychiatric Research (C.F.Z., S.M.), Department of Anatomy & Neurobiology (C.F.Z., S.M.), Washington University School of Medicine, St. Louis, Missouri; and Department of Clinical and Molecular Biomedicine (M.C.), Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Mennerick
Department of Psychiatry (A.J.L, A.Y.,H-J. S., C.F.Z., S.M.), Taylor Family Institute for Innovative Psychiatric Research (C.F.Z., S.M.), Department of Anatomy & Neurobiology (C.F.Z., S.M.), Washington University School of Medicine, St. Louis, Missouri; and Department of Clinical and Molecular Biomedicine (M.C.), Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

NMDA receptor (NMDAR) antagonists are dissociative anesthetics, drugs of abuse, and are of therapeutic interest in neurodegeneration and neuropsychiatric disease. Many well-known NMDAR antagonists are positively charged, voltage-dependent channel blockers. We recently showed that the hydrophobic anion dipicrylamine (DPA) negatively regulates GABAA receptor function by a mechanism indistinguishable from that of sulfated neurosteroids. Because sulfated neurosteroids also modulate NMDARs, here we examined the effects of DPA on NMDAR function. In rat hippocampal neurons DPA inhibited currents gated by 300 µM NMDA with an IC50 of 2.3 µM. Neither onset nor offset of antagonism exhibited dependence on channel activation but exhibited a noncompetitive profile. DPA antagonism was independent of NMDAR subunit composition and was similar at extrasynaptic and total receptor populations. Surprisingly, similar to cationic channel blockers but unlike sulfated neurosteroids, DPA antagonism was voltage dependent. Onset and offset of DPA antagonism were nearly 10-fold faster than DPA-induced increases in membrane capacitance, suggesting that membrane interactions do not directly explain antagonism. Furthermore, voltage dependence did not derive from association of DPA with a site on NMDARs directly accessible to the outer membrane leaflet, assessed by DPA translocation experiments. Consistent with the expected lack of channel block, DPA antagonism did not interact with permeant ions. Therefore, we speculate that voltage dependence may arise from interactions of DPA with the inherent voltage dependence of channel gating. Overall, we conclude that DPA noncompetitively inhibits NMDA-induced current by a novel voltage-dependent mechanism and represents a new class of anionic NMDAR antagonists.

Footnotes

  • This work was supported by the Bantly Foundation; the National Institutes of Health National Institute on Drug Abuse [Grant DA07261]; the National Institutes of Health National Institute of Mental Health [Grants MH078823 and MH 077791]; the National Institutes of Health National Institute on Alcohol Abuse and Alcoholism [Grant AA017413]; the National Institutes of Health National Institute of General Medical Sciences [Grant GM47969]; and the International Promotion of Young Researchers “Montalcini Program,” sponsored by the Italian Ministry of Education, University and Research.

  • dx.doi.org/10.1124/mol.112.081794.

  • Received August 10, 2012.
  • Accepted November 9, 2012.
  • Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 83 (2)
Molecular Pharmacology
Vol. 83, Issue 2
1 Feb 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Noncompetitive, Voltage-Dependent NMDA Receptor Antagonism by Hydrophobic Anions
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

NMDAR Antagonism by an Anion

Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
Molecular Pharmacology February 1, 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

NMDAR Antagonism by an Anion

Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
Molecular Pharmacology February 1, 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of action of a TARP subtype-selective drug
  • Kir4.1/5.1 inhibitor VU6036720
  • Myosin Activators/Inhibitors in Immature Cardiac Sarcomeres
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics